DexCom (DXCM) Tops Q1 EPS by 9c; offers guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.35 +1.61%
EPS Growth %: +9.8%
Financial Fact:
Operating loss: -18.5M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +9.8%
Financial Fact:
Operating loss: -18.5M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.56, $0.09 better than the analyst estimate of $0.47. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.17 billion.
GUIDANCE:
DexCom sees FY2026 revenue of $5.16-5.25 billion, versus the consensus of $5.226 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Axion Minerals plans flow-through private placement of up to $440K
- Fold Holdings (FLD) files for 51.23M share offering by selling stockholders
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
